IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS

被引:2204
作者
MECHOULAM, R
BENSHABAT, S
HANUS, L
LIGUMSKY, M
KAMINSKI, NE
SCHATZ, AR
GOPHER, A
ALMOG, S
MARTIN, BR
COMPTON, DR
PERTWEE, RG
GRIFFIN, G
BAYEWITCH, M
BARG, J
VOGEL, Z
机构
[1] MICHIGAN STATE UNIV,DEPT PHARMACOL & TOXICOL,E LANSING,MI 48824
[2] CHAIM SHEBA MED CTR,INST CLIN PHARMACOL & TOXICOL,IL-52621 TEL HASHOMER,ISRAEL
[3] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
[4] UNIV ABERDEEN,MARISCHAL COLL,DEPT BIOMED SCI,ABERDEEN AB9 1AS,SCOTLAND
[5] WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL
基金
英国惠康基金;
关键词
2-ARACHIDONYL GLYCEROL; ANAND AMIDE; TETRAHYDROCANNABINOL; ARACHIDONYLETHANOLAMIDE; IMMUNE SYSTEM; TRANSFECTION; MOUSE BEHAVIOR; ADENYLATE CYCLASE INHIBITION;
D O I
10.1016/0006-2952(95)00109-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl). Its structure was determined by mass spectrometry and by direct comparison with a synthetic sample. 2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2-the two cannabinoid receptors identified thus far-with K-i values of 472 +/- 55 and 1400 +/- 172 nM, respectively. In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at the potency level of Delta(9)-tetrahydrocannabinol (Delta(9)-THC). Upon intravenous administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, reduction of spontaneous activity, and lowering of the rectal temperature. 2-Ara-Gl also shares the ability of Delta(9)-THC to inhibit electrically evoked contractions of mouse isolated vasa deferentia; however, it was less potent than Delta(9)-THC.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 37 条
[11]   PHARMACOLOGICAL ACTIVITY OF THE CANNABINOID RECEPTOR AGONIST, ANANDAMIDE, A BRAIN CONSTITUENT [J].
FRIDE, E ;
MECHOULAM, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) :313-314
[12]  
GAONI Y, 1991, J AM CHEM SOC, V93, P217
[13]   MOLECULAR-CLONING OF A HUMAN CANNABINOID RECEPTOR WHICH IS ALSO EXPRESSED IN TESTIS [J].
GERARD, CM ;
MOLLEREAU, C ;
VASSART, G ;
PARMENTIER, M .
BIOCHEMICAL JOURNAL, 1991, 279 :129-134
[14]  
GUNSTONE FD, 1979, COMPREHENSIVE ORGANI, V5, P633
[15]   2 NEW UNSATURATED FATTY-ACID ETHANOLAMIDES IN BRAIN THAT BIND TO THE CANNABINOID RECEPTOR [J].
HANUS, L ;
GOPHER, A ;
ALMOG, S ;
MECHOULAM, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (20) :3032-3034
[16]  
JARBE TUC, 1993, J PHARMACOL EXP THER, V264, P561
[17]  
KAMINSKI NE, 1992, MOL PHARMACOL, V42, P736
[18]   SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY CANNABINOIDS IS PARTIALLY MEDIATED THROUGH INHIBITION OF ADENYLATE-CYCLASE BY A PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN COUPLED MECHANISM [J].
KAMINSKI, NE ;
KOH, WS ;
YANG, KH ;
LEE, M ;
KESSLER, FK .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1899-1908
[19]   CANNABINOIDS - STRUCTURE-ACTIVITY STUDIES RELATED TO 1,2-DIMETHYLHEPTYL DERIVATIVES [J].
LOEV, B ;
BENDER, PE ;
DOWALO, F ;
MACKO, E ;
FOWLER, PJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) :1200-1206
[20]  
LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612